1. Home
  2. INTZ vs BCDA Comparison

INTZ vs BCDA Comparison

Compare INTZ & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.73

Market Cap

15.7M

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$0.95

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
BCDA
Founded
1983
N/A
Country
United States
United States
Employees
52
21
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
12.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INTZ
BCDA
Price
$0.73
$0.95
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.75
$25.00
AVG Volume (30 Days)
136.6K
5.7M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.78
N/A
EPS
N/A
N/A
Revenue
$7,015,000.00
N/A
Revenue This Year
$25.34
N/A
Revenue Next Year
$14.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.56
N/A
52 Week Low
$0.69
$0.84
52 Week High
$2.64
$2.45

Technical Indicators

Market Signals
Indicator
INTZ
BCDA
Relative Strength Index (RSI) 41.95 44.29
Support Level N/A $0.84
Resistance Level $1.20 $1.36
Average True Range (ATR) 0.06 0.12
MACD -0.00 0.01
Stochastic Oscillator 14.81 7.36

Price Performance

Historical Comparison
INTZ
BCDA

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: